138 related articles for article (PubMed ID: 28415995)
1. Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.
Barrett BS; Harper MS; Jones ST; Guo K; Heilman KJ; Kedl RM; Hasenkrug KJ; Santiago ML
Retrovirology; 2017 Apr; 14(1):25. PubMed ID: 28415995
[TBL] [Abstract][Full Text] [Related]
2. Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.
Halemano K; Barrett BS; Heilman KJ; Morrison TE; Santiago ML
J Virol; 2015 Apr; 89(7):4011-4. PubMed ID: 25589647
[TBL] [Abstract][Full Text] [Related]
3. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
Smith DS; Guo K; Barrett BS; Heilman KJ; Evans LH; Hasenkrug KJ; Greene WC; Santiago ML
PLoS Pathog; 2011 Oct; 7(10):e1002284. PubMed ID: 21998583
[TBL] [Abstract][Full Text] [Related]
4. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.
Santiago ML; Benitez RL; Montano M; Hasenkrug KJ; Greene WC
J Immunol; 2010 Jul; 185(2):1114-23. PubMed ID: 20566830
[TBL] [Abstract][Full Text] [Related]
5. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
Santiago ML; Montano M; Benitez R; Messer RJ; Yonemoto W; Chesebro B; Hasenkrug KJ; Greene WC
Science; 2008 Sep; 321(5894):1343-6. PubMed ID: 18772436
[TBL] [Abstract][Full Text] [Related]
6. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.
Tsuji-Kawahara S; Chikaishi T; Takeda E; Kato M; Kinoshita S; Kajiwara E; Takamura S; Miyazawa M
J Virol; 2010 Jun; 84(12):6082-95. PubMed ID: 20375169
[TBL] [Abstract][Full Text] [Related]
7. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.
Santiago ML; Smith DS; Barrett BS; Montano M; Benitez RL; Pelanda R; Hasenkrug KJ; Greene WC
J Virol; 2011 Jan; 85(1):189-99. PubMed ID: 20980520
[TBL] [Abstract][Full Text] [Related]
8. IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.
Harper MS; Barrett BS; Smith DS; Li SX; Gibbert K; Dittmer U; Hasenkrug KJ; Santiago ML
J Immunol; 2013 Feb; 190(4):1583-90. PubMed ID: 23315078
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection.
Halemano K; Guo K; Heilman KJ; Barrett BS; Smith DS; Hasenkrug KJ; Santiago ML
Proc Natl Acad Sci U S A; 2014 May; 111(21):7759-64. PubMed ID: 24821801
[TBL] [Abstract][Full Text] [Related]
10. Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice.
Halemano K; Barrett BS; Li SX; Harper MS; Smith DS; Heilman KJ; Santiago ML
PLoS One; 2013; 8(3):e60500. PubMed ID: 23533681
[TBL] [Abstract][Full Text] [Related]
11. Effects of type I interferons on Friend retrovirus infection.
Gerlach N; Schimmer S; Weiss S; Kalinke U; Dittmer U
J Virol; 2006 Apr; 80(7):3438-44. PubMed ID: 16537611
[TBL] [Abstract][Full Text] [Related]
12. Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.
Li SX; Barrett BS; Guo K; Kassiotis G; Hasenkrug KJ; Dittmer U; Gibbert K; Santiago ML
Sci Rep; 2016 Feb; 6():20425. PubMed ID: 26846717
[TBL] [Abstract][Full Text] [Related]
13. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.
Barrett BS; Guo K; Harper MS; Li SX; Heilman KJ; Davidson NO; Santiago ML
Virology; 2014 Nov; 468-470():601-608. PubMed ID: 25303118
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.
Kochs G; Anzaghe M; Kronhart S; Wagner V; Gogesch P; Scheu S; Lienenklaus S; Waibler Z
J Virol; 2016 Oct; 90(20):9330-7. PubMed ID: 27512061
[TBL] [Abstract][Full Text] [Related]
15. Deaminase-Dead Mouse APOBEC3 Is an
Stavrou S; Zhao W; Blouch K; Ross SR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
[TBL] [Abstract][Full Text] [Related]
16. Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.
Robertson SJ; Ammann CG; Messer RJ; Carmody AB; Myers L; Dittmer U; Nair S; Gerlach N; Evans LH; Cafruny WA; Hasenkrug KJ
J Virol; 2008 Jan; 82(1):408-18. PubMed ID: 17959678
[TBL] [Abstract][Full Text] [Related]
17. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.
Takeda E; Tsuji-Kawahara S; Sakamoto M; Langlois MA; Neuberger MS; Rada C; Miyazawa M
J Virol; 2008 Nov; 82(22):10998-1008. PubMed ID: 18786991
[TBL] [Abstract][Full Text] [Related]
18. Negative impact of IFN-γ on early host immune responses to retroviral infection.
Duley AK; Ploquin MJ; Eksmond U; Ammann CG; Messer RJ; Myers L; Hasenkrug KJ; Kassiotis G
J Immunol; 2012 Sep; 189(5):2521-9. PubMed ID: 22821964
[TBL] [Abstract][Full Text] [Related]
19. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
[TBL] [Abstract][Full Text] [Related]
20. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
Zaritsky LA; Bedsaul JR; Zoon KC
J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
